One swallow does not make a summer in our view, but the Q2 figures looked sequentially and yoy much stronger. Care Delivery made the strongest contribution, whereas Care Enablement’s margin still has a long way to go to reach the target level. The management was confident that the company could report a stronger H2 over H1.
The Q2 was above our expectations and a strong beat to consensus at many of the profitability levels (revenues: +0.7%; EBIT: +28.9%; net profit: +47.7%). Investors have som ....

07 Aug 2023
Accelerated business performance allows for guidance adjustment

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Accelerated business performance allows for guidance adjustment
Fresenius Medical Care AG (FME:ETR) | 0 0 0.0%
- Published:
07 Aug 2023 -
Author:
Martin Schnee -
Pages:
4 -
One swallow does not make a summer in our view, but the Q2 figures looked sequentially and yoy much stronger. Care Delivery made the strongest contribution, whereas Care Enablement’s margin still has a long way to go to reach the target level. The management was confident that the company could report a stronger H2 over H1.
The Q2 was above our expectations and a strong beat to consensus at many of the profitability levels (revenues: +0.7%; EBIT: +28.9%; net profit: +47.7%). Investors have som ....